<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35749364</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>26</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Retromer dysfunction in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e2118755119</StartPage><MedlinePgn>e2118755119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2118755119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2118755119</ELocationID><Abstract><AbstractText>Retromer is a heteropentameric complex that plays a specialized role in endosomal protein sorting and trafficking. Here, we report a reduction in the retromer proteins-vacuolar protein sorting 35 (VPS35), VPS26A, and VPS29-in patients with amyotrophic lateral sclerosis (ALS) and in the ALS model provided by transgenic (Tg) mice expressing the mutant superoxide dismutase-1 G93A. These changes are accompanied by a reduction of levels of the &#x3b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluA1, a proxy of retromer function, in spinal cords from Tg SOD1<sup>G93A</sup> mice. Correction of the retromer deficit by a viral vector expressing <i>VPS35</i> exacerbates the paralytic phenotype in Tg SOD1<sup>G93A</sup> mice. Conversely, lowering <i>Vps35</i> levels in Tg SOD1<sup>G93A</sup> mice ameliorates the disease phenotype. In light of these findings, we propose that mild alterations in retromer inversely modulate neurodegeneration propensity in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-Torres</LastName><ForeName>Eduardo J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utkina-Sosunova</LastName><ForeName>Irina</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5352-5797</Identifier><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Vartika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbuti</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Planell-Saguer</LastName><ForeName>Mariangels</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dermentzaki</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiger</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Computational Biology, New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basile</LastName><ForeName>Anna O</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0000-0001-5112-5880</Identifier><AffiliationInfo><Affiliation>Computational Biology, New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robine</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Computational Biology, New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagegaltier</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Politi</LastName><ForeName>Kristin A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinchetti</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8279-3304</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson-Lewis</LastName><ForeName>Vernice</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NYGC ALS Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phatnani</LastName><ForeName>Hemali</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6571-3891</Identifier><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5104-9088</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Przedborski</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Diseases, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM007367</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498296">VPS26A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C419572">VPS29 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C419573">VPS35 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C101274">Vps35 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="Y">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">retromer</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35749364</ArticleId><ArticleId IdType="pmc">PMC9245686</ArticleId><ArticleId IdType="doi">10.1073/pnas.2118755119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Seaman M. N. J., The retromer complex: From genesis to revelations. Trends Biochem. Sci. 46, 608&#x2013;620 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33526371</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang F. L., et al. , VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep. 12, 1631&#x2013;1643 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565770</ArticleId><ArticleId IdType="pubmed">26321632</ArticleId></ArticleIdList></Reference><Reference><Citation>Small S. A., et al. , Model-guided microarray implicates the retromer complex in Alzheimer&#x2019;s disease. Ann. Neurol. 58, 909&#x2013;919 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16315276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., et al. , Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers. Brain 141, 486&#x2013;495 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837795</ArticleId><ArticleId IdType="pubmed">29253086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., et al. , Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down&#x2019;s syndrome. Nat. Med. 19, 473&#x2013;480 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911880</ArticleId><ArticleId IdType="pubmed">23524343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagnozzi A. N., et al. , VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol. Psychiatry 26, 6992&#x2013;7005 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949432</ArticleId><ArticleId IdType="pubmed">31289348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J., Pratic&#xf2; D., The retromer complex system in a transgenic mouse model of AD: Influence of age. Neurobiol. Aging 52, 32&#x2013;38 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28110103</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLeod D. A., et al. , RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson&#x2019;s disease risk. Neuron 77, 425&#x2013;439 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3646583</ArticleId><ArticleId IdType="pubmed">23395371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavodszky E., et al. , Mutation in VPS35 associated with Parkinson&#x2019;s disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 5, 3828 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024763</ArticleId><ArticleId IdType="pubmed">24819384</ArticleId></ArticleIdList></Reference><Reference><Citation>McGough I. J., et al. , Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. Curr. Biol. 24, 1670&#x2013;1676 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4110399</ArticleId><ArticleId IdType="pubmed">24980502</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilari&#xf1;o-G&#xfc;ell C., et al. , VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 89, 162&#x2013;167 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135796</ArticleId><ArticleId IdType="pubmed">21763482</ArticleId></ArticleIdList></Reference><Reference><Citation>Follett J., et al. , The Vps35 D620N mutation linked to Parkinson&#x2019;s disease disrupts the cargo sorting function of retromer. Traffic 15, 230&#x2013;244 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24152121</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A., et al. , A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168&#x2013;175 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135812</ArticleId><ArticleId IdType="pubmed">21763483</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzio L., et al. , Retromer stabilization results in neuroprotection in a model of amyotrophic lateral sclerosis. Nat. Commun. 11, 3848 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395176</ArticleId><ArticleId IdType="pubmed">32737286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L. P., Mitsumoto H., Przedborski S., &#x201c;Amyotrophic lateral sclerosis, progressive muscular atrophy and primary lateral sclerosis&#x201d; in Merritt&#x2019;s Neurology, Rowland L. P., Pedley T. A., Eds. (Lippincott, Williams &amp; Wilkins, Philadelphia, PA, 2010), chap. 128, pp. 802&#x2013;808.</Citation></Reference><Reference><Citation>Feigin V. L., et al. ; GBD 2016 Neurology Collaborators, Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459&#x2013;480 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459001</ArticleId><ArticleId IdType="pubmed">30879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., et al. ; GBD 2016 Motor Neuron Disease Collaborators, Global, regional, and national burden of motor neuron diseases 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 1083&#x2013;1097 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Kikuchi H., Przedborski S., &#x201c;Experimental models of motor neuron diseases&#x201d; in Amyotrophic Lateral Sclerosis, Mitsumoto H., Przedborski S., Gordon P. H., Eds. (Taylor &amp; Francis, New York, NY, 2006), chap. 24, pp. 525&#x2013;549.</Citation></Reference><Reference><Citation>Van Harten A. C. M., Phatnani H., Przedborski S., Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. 44, 658&#x2013;668 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D. B., et al. , Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81, 1001&#x2013;1008 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., et al. , Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14, 796&#x2013;809 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y., et al. , Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 33, 89&#x2013;96 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., et al. , Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89&#x2013;93 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlotta P., et al. , Neuronal subtype-specific genes that control corticospinal motor neuron development in&#xa0;vivo. Neuron 45, 207&#x2013;221 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15664173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler P. H., et al. , Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G93A transgenic ALS mice. J. Neurosci. 31, 4166&#x2013;4177 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J. G., Chiu J., Pratic&#xf2; D., Full recovery of the Alzheimer&#x2019;s disease phenotype by gain of function of vacuolar protein sorting 35. Mol. Psychiatry 25, 2630&#x2013;2640 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6685773</ArticleId><ArticleId IdType="pubmed">30733594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang F. L., et al. , VPS35 in dopamine neurons is required for Endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for &#x3b1;-synuclein degradation and prevention of pathogenesis of Parkinson&#x2019;s disease. J. Neurosci. 35, 10613&#x2013;10628 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4510296</ArticleId><ArticleId IdType="pubmed">26203154</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoes S., et al. , Tau and other proteins found in Alzheimer&#x2019;s disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans. Sci. Transl. Med. 12, eaba6334 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901670</ArticleId><ArticleId IdType="pubmed">33239387</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek R. A. A., et al. ; Project MinE ALS Sequencing Consortium, The project MinE databrowser: Bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 432&#x2013;440 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E. T., et al. ; FALS Sequencing Consortium, Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436&#x2013;1441 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardarajan B. N., et al. , Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiol. Aging 33, 2231.e15&#x2013;2231.e30 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391348</ArticleId><ArticleId IdType="pubmed">22673115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardarajan B. N., et al. , Coding mutations in SORL1 and Alzheimer disease. Ann. Neurol. 77, 215&#x2013;227 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4367199</ArticleId><ArticleId IdType="pubmed">25382023</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz C., et al. ; Alzheimer&#x2019;s Disease Genetics Consortium (ADGC), Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl. Psychiatry 3, e256 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3669917</ArticleId><ArticleId IdType="pubmed">23673467</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt-John T., et al. , Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 37, 1213&#x2013;1215 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16244655</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisler M. H., et al. , Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS. Amyotroph. Lateral Scler. 9, 141&#x2013;148 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18574757</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher J. K., Tabet R., Yeo G. W., Lagier-Tourenne C., Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron 102, 294&#x2013;320 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S. A., RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 9, 712 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo L., et al. , Fluorimetric detection of the earliest events in amyloid &#x3b2; oligomerization and its inhibition by pharmacologically active liposomes. Biochim. Biophys. Acta 1860, 746&#x2013;756 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26774643</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., et al. , Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS. Part I. Background and methods. Brain Behav. 3, 335&#x2013;350 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning K. C., Kaplan A., Henderson C. E., Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 33, 409&#x2013;440 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Munsie L. N., et al. , Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson&#x2019;s disease VPS35 mutation p.D620N. Hum. Mol. Genet. 24, 1691&#x2013;1703 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25416282</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Alstyne M., et al. , Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit. Nat. Neurosci. 24, 930&#x2013;940 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254787</ArticleId><ArticleId IdType="pubmed">33795885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Rothstein J. D., Kiernan M. C., Advances in treating amyotrophic lateral sclerosis: Insights from pathophysiological studies. Trends Neurosci. 37, 433&#x2013;442 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24927875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V., et al. , Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun. 11, 5579 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton M. J., et al. , Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer&#x2019;s disease-associated genes. Proc. Natl. Acad. Sci. U.S.A. 118, e2112095118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719885</ArticleId><ArticleId IdType="pubmed">34949639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargent D., et al. , Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality. Brain Commun. 3, fcab208 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445400</ArticleId><ArticleId IdType="pubmed">34704029</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk F., Baron U., Rajewsky K., A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080&#x2013;5081 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC307516</ArticleId><ArticleId IdType="pubmed">8559668</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres E. J., &#x201c;Retromer deficiency in amyotrophic lateral sclerosis,&#x201d; PhD thesis, Columbia University, New York, NY (2020).</Citation></Reference><Reference><Citation>Nagai M., et al. , Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615&#x2013;622 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groot C. J., et al. , Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: Immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342&#x2013;354 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9260745</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., et al. ; Edaravone ALS Study Group, Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 15, 610&#x2013;617 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon C. M., et al. , Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy. Cell Rep. 29, 3885&#x2013;3901.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6956708</ArticleId><ArticleId IdType="pubmed">31851921</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S., et al. , Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp. Anim. 64, 147&#x2013;153 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4427729</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O. H., et al. ; NYGC ALS Consortium, Postmortem cortex samples identify distinct molecular subtypes of ALS: Retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 29, 1164&#x2013;1177.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Project MinE ALS Sequencing Consortium, Project MinE: Study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 26, 1537&#x2013;1546 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>